OSUR OraSure: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization

OraSure Technologies Inc - graphic logo of issuer OSUR

OraSure Technologies (OSUR) is creating a comprehensive environment for rapid diagnostics by combining simple tests with digital health monitoring. The asset's EV/EBITDA market value dynamics, which stand at 0.00, are based on a stable financial position and reliable cash flow. This enables the company to scale biomaterial collection and implement advanced molecular research to achieve leadership in the rapid testing segment.

OraSure Technologies Inc - OSUR Total Company Value to Operating Income Before Depreciation Ratio (period 11/23/2025 - 11/11/2026)

OSUR (orasure.com): analytical breakdowns and indicator data

- stock price and consensus target price:
Stock Quotes OraSure Technologies Inc|OSUR - Average Forecast Price
- company stock capitalization data:
Market Value OraSure Corp|OSUR - Company Buyout Price
- book value of equity indicators:
Book Value per Share OraSure|OSUR - Book Valuation of Business|Market Value to Book Value Ratio orasure.com|OSUR - Company Total Asset Base
- company liabilities and liquidity data:
Debt to Equity OraSure Technologies|OSUR - Long-Term Liabilities to Capital|Short-Term Debt to Equity OraSure|OSUR - Aggregate Debt Obligations|Debts to Book Capitalization OraSure Corp|OSUR - Company Long-Term Debts|Company Short-Term Debt OraSure|Quick Liquidity Indicator orasure.com
- financial results and valuation multiples details:
OSUR - Net Profit|Expected Profit OraSure Technologies|OSUR - Company Value to Net Income|Forward P/E Multiple OraSure Technologies|OSUR - Price to Earnings Adjusted for Growth Rate|Enterprise Value to EBITDA Ratio OraSure Corp|OSUR - Income before deduction of interest, taxes and amortization|Net earnings per share for the last 12 months OraSure|OSUR - Earnings per share for the last four quarters|Quarterly EPS earnings growth orasure.com|OSUR - Earnings per share growth rate in current year|Earnings growth forecast for next year OraSure Technologies
Summary company analysis:OraSure Technologies Inc OSUR
Original product of OraSure

This indicator compares the total enterprise value, including net debt, with operating profit before depreciation and amortization. Investors utilize this metric to determine the fair value of an asset by excluding the impact of tax policy and financing structure. By analyzing the EV/EBITDA ratio alongside financial leverage, one can assess the resilience of OraSure Technologies (OSUR) to a decline in demand for COVID tests. Current price action reflects market expectations regarding the company's ability to maintain margins amidst fierce competition.

Competitors of OraSure Technologies

Agilent Tech - Enterprise Value to EBITDA Ratio|Quest Corp (DGX) - Company Value to EBITDA|ILMN - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio exactsciences.com EXAS|RVTY: EV/EBITDA Multiple|BIO - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Anbio Tech|Nordion (SHC) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization QuidelOrtho (QDEL)|OPK - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization CareDx Inc CDNA|Business Value to Operating Income Before Depreciation MRVI|Fulgent Corp - EV/EBITDA Multiple|LAB - EV/EBITDA Multiple|Cytek Biosciences, Inc. (CTKB) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|XGN - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio MDXH|EV/EBITDA Multiple Lucid Diagnostics, Inc.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Prenetics Global (PRE)|IMDX (imdxinc.com) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple TRIB (Trinity Biotech)|prophaselabs.com (PRPH) - Company Value to EBITDA|AIMD: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation CODX (Co-Diagnostics Inc)|HSCS (Heart Test Laboratories Inc.) - Enterprise Value to EBITDA Ratio|BMRA: Enterprise Value to Operating Income Before Depreciation Ratio|CDIO (Cardio Diagnostics Holdings Inc.) - EV/EBITDA Multiple|Company Value to EBITDA onconetix.gcs-web.com ONCO|EV/EBITDA Multiple VRAX|Enterprise Value to EBITDA Ratio Bluejay Diagnostics Inc BJDX|EV/EBITDA Multiple AWH (Vermillion)|Business Value to Operating Income Before Depreciation AXDX|CNTG - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ENZ (Enzo Biochem, Inc.) - Enterprise Value to Operating Income Before Depreciation|fresh2.co (FRES) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA Genetic Technologies Limited (GENE)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization 23andMe Inc.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization PMD